Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 66 entries
View as:

Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02621385 Org: User:
Start: 11/30/15 End: - Due: -

VEC-162 Study in Adult Patients With Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00548340 Org: User:
Start: 11/30/07 End: 06/30/08 Due: 06/30/09

Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06323655 Org: User:
Start: 07/19/18 End: 08/28/18 Due: 08/28/19

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04819776 Org: User:
Start: 03/22/21 End: 08/16/23 Due: 08/16/24

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT03373201 Org: User:
Start: 10/16/17 End: 03/05/18 Due: 03/05/19

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Phase: N/A Priority: Normal
NCT ID: NCT03568331 Org: User:
Start: 07/09/18 End: 12/27/19 Due: 12/27/20

A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT04712734 Org: User:
Start: 01/13/21 End: 08/30/22 Due: 08/30/23

Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06494397 Org: User:
Start: 07/31/24 End: 09/30/24 Due: 09/30/25

Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)

Phase: N/A Priority: Normal
NCT ID: NCT02130999 Org: User:
Start: 05/31/14 End: 05/31/14 Due: 05/31/15

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01430754 Org: User:
Start: 09/30/11 End: 12/31/12 Due: 12/31/13

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Phase: N/A Priority: Normal
NCT ID: NCT06138613 Org: User:
Start: 02/27/23 End: 04/30/25 Due: 04/30/26

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

Phase: N/A Priority: Normal
NCT ID: NCT05361707 Org: User:
Start: 07/28/21 End: 07/31/25 Due: 07/31/26

Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02004041 Org: User:
Start: 12/10/13 End: 02/19/15 Due: 02/19/16

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT04028492 Org: User:
Start: 08/20/19 End: 12/31/24 Due: 12/31/25

An Observational Study to Investigate the Effects of Rapid Transmeridian Travel

Phase: N/A Priority: Normal
NCT ID: NCT02560103 Org: User:
Start: 09/30/15 End: 10/31/17 Due: 10/31/18

Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04849559 Org: User:
Start: 02/01/21 End: 09/24/21 Due: 09/24/22

Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01477619 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT04127058 Org: User:
Start: 10/07/19 End: 11/27/19 Due: 11/27/20

Food Effect Study of VHX-896 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06803290 Org: User:
Start: 06/21/22 End: 12/27/22 Due: 12/27/23

Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception

Phase: N/A Priority: Normal
NCT ID: NCT01429116 Org: User:
Start: 10/31/11 End: 01/31/15 Due: 01/31/16

A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03291041 Org: User:
Start: 07/31/16 End: 11/30/17 Due: 11/30/18

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT05648591 Org: User:
Start: 05/24/23 End: 11/30/26 Due: 11/30/27

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04326426 Org: User:
Start: 04/13/20 End: 08/31/20 Due: 08/31/21

WGS Analysis of COVID-19 Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT04353401 Org: User:
Start: 08/03/20 End: 03/09/22 Due: 03/09/23

Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02776215 Org: User:
Start: 10/04/16 End: 12/20/17 Due: 12/20/18